Defining molecular determinants of Plasmodium falciparum hematopoietic infection using single cell profiling and genetics
Lead Research Organisation:
University of Glasgow
Department Name: College of Medical, Veterinary, Life Sci
Abstract
Plasmodium falciparum (Pf) malaria remains a leading cause of death in many low- and middle-income countries, particularly in Sub-Saharan Africa. Further exploration into uncharacterized areas of parasite biology within the human host is essential for identifying novel avenues for antimalarial therapies, transmission-blocking strategies, and/or diagnostics aimed at reducing the global disease burden. Recent work has identified the hematopoietic niches of the bone and spleen as major sites of Pf parasite replication and development. Importantly, these organs serve both as extravascular reservoirs for asexual blood-stage parasites that cause clinical symptoms of malaria, and as sites for development of gametocytes, sexual stages that are required for transmission between human hosts. Nonetheless, the relative inaccessibility of these organs in humans and their highly heterogenous composition has impeded our understanding of the mechanisms underlying parasite replication and differentiation within these niches. Blood-stage parasites also have the capacity to invade erythrocytes of various maturation states, further contributing to the heterogeneity of infection within the hematopoietic niche. Single cell methods provide unprecedented opportunities to investigate these complex processes at exceptionally high resolution. Here, I propose to leverage these technologies, in combination with reverse genetics, to dissect the respective contributions of host cell-intrinsic and -extrinsic factors to parasite development in the hematopoietic niche. I hypothesize that Pf blood-stage parasites transcriptionally adapt both to their external organ environment and to their specific host cell, leading to major changes in parasite biology that can drive pathology, impact transmission, and affect antimalarial drug responses.
| Title | Dual host-parasite single cell RNA sequencing for Plasmodium falciparum malaria parasites |
| Description | Method for isolating performing dual-host parasite single cell RNA sequencing of malaria-infected erythryoctes derived from human bone marrow aspirates or human peripheral blood samples. Can be applied to patient-derived naturally infected samples or in vitro cultures. Designed for the 10x Genomics platform. Steps include sample preparation, antibody labeling of cell surface proteins, loading of samples for 10x processing, generation of cDNA and targeted depletion of globin transcripts, library preparation & sequencing. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2023 |
| Provided To Others? | No |
| Impact | This method has allowed our group to study parasite development and differentiation in the bone marrow in both in vitro and ex vivo patient samples. Recent work has identified the hematopoietic niche of the bone marrow as a major site of malaria parasite replication and development. Importantly, the bone marrow serves both as extravascular reservoir for asexual blood-stage parasites that cause clinical symptoms of malaria, and as a site for development of gametocytes, sexual stages that are required for transmission between human hosts. However, the relative inaccessibility of bone marrow in humans and its heterogenous composition has impeded our ability to study parasite development therein. Dual host-parasite single cell RNA sequencing allows us to characterise transcriptional differences between parasites in the periphery versus those sequestered in the bone marrow, as well as to characterise transcriptional changes to host cells induced by parasite infection. Ultimately these data may influence approaches to treatment and inform development of transmission-blocking therapies. |
| Title | In vitro cell culture of Plasmodium falciparum malaria parasites in bone-marrow derived cells |
| Description | Method for isolating reticulocytes from human bone marrow aspirates and establishing in vitro cultures of Plasmodium falciparum parasites in bone-marrow derived cells. Steps include filtration, removal of leukocytes, enrichment of reticulocytes via CD71 microbeads, validation of reticulocyte population, and infection with P. falciparum schizonts. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2023 |
| Provided To Others? | No |
| Impact | This method has allowed our group and others to study parasite development and differentiation in the bone marrow in vitro. Recent work has identified the hematopoietic niche of the bone marrow as a major site of malaria parasite replication and development. Importantly, the bone marrow serves both as extravascular reservoir for asexual blood-stage parasites that cause clinical symptoms of malaria, and as a site for development of gametocytes, sexual stages that are required for transmission between human hosts. However, the relative inaccessibility of bone marrow in humans and its heterogenous composition has impeded our ability to study parasite development therein. Culturing parasites in vitro in primary human bone marrow cells has enabled us to make important insights into the biology of parasite replication and differentiation that will potentially influence approaches to treatment and development of transmission-blocking therapies. |
| Description | Kamuzu University of Health Sciences (KUHeS) (Dr. Karl Seydel) |
| Organisation | Kamuzu University of Health Sciences |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Contributions made by our research team to the collaboration include: -Expertise in parasitology (specifically in the area of malaria biology and transmission) -Intellectual input (in the form of participation in lab meeting presentations & journal clubs, help with interview preparation, review of abstracts, publications, grant submissions, etc.) |
| Collaborator Contribution | Contributions made by our partners to the collaboration include: -Clinical study coordination and management of ethics approvals -Access to clinical samples (blood samples from malaria-infected patients) |
| Impact | Research Tools & Methods |
| Start Year | 2023 |
| Description | Malawi Liverpool Wellcome Programme (Dr. Christopher Moxon) |
| Organisation | Wellcome Trust |
| Department | Malawi-Liverpool Wellcome Trust Clinical Research Programme |
| Country | Malawi |
| Sector | Academic/University |
| PI Contribution | Contributions made by our research team to the collaboration include: -Expertise in parasitology (specifically in the area of malaria biology and transmission) -Intellectual input (in the form of participation in lab meeting presentations & journal clubs, help with interview preparation, review of abstracts, publications, grant submissions, etc.) -Training of staff in methods relating to single cell RNA sequencing and parasite biology (cell culture & others) -Access to equipment for single cell RNA sequencing & other techniques -Access to CL3 culture facilities -Funding for equipment, consumables, sequencing costs, etc. -Funding for travel (visits for collaboration) |
| Collaborator Contribution | Contributions made by our partners *M to the collaboration include: -Clinical study coordination and management of ethics approvals -Access to clinical samples (venous blood and bone marrow) -Expertise in immunology (specifically in the area of cerebral malaria and disease pathogenesis) -Intellectual input (in the form of participation in lab meeting presentations & journal clubs, help with interview preparation, review of abstracts, publications, grant submissions, etc.) -Training of staff in methods relating to immunology (isolation of immune cell subsets, immunophenotyping, etc.) -Access to equipment for single cell RNA sequencing & other techniques -Funding for consumables & sequencing costs, etc. |
| Impact | Research tools & methods |
| Start Year | 2023 |
| Description | AfriBOP |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | Mentor for AfriBOP. AfriBOP is a week-long course targeted at primarily at postgraduate students (MSc and Phd) from Africa who have a strong interest in interactions between the immune system and pathogens, and how these underly the pathogenesis of a wide range of infectious and non-communicable diseases. The course constitutes intensive, interactive learning sessions in topics relating to immunology and infection biology. Students also benefit from grant writing, science communication and career-mentoring sessions. The course is offered free of charge to accepted students and is sponsored by the University of Glasgow, the Malawi Liverpool Wellcome Programme, and the KEMRI-Wellcome Trust Research Programme Many students who participate in the course develop long-lasting connections that help them to advance in their careers and go on to competitive postgraduate programs, postdoctoral positions, or to establish independent research careers. |
| Year(s) Of Engagement Activity | 2025 |
